Cart
×
CureDuchenne’s Vine Time
More than $900,000 will go to support CureDuchenne’s mission to find a cure for Duchenne muscular dystrophy and support patients and families affected by this rare genetic disease, all thanks to […]
Edasalonexent in Development for the Treatment of Duchenne: Information on Three Clinical Trials
Join to learn about edasalonexent, a novel oral NF-kB inhibitor in development for the treatment of Duchenne muscular dystrophy, regardless of mutation type. This webinar will include: An update on […]
Catabasis Connection – March 2019
In the latest Catabasis Connection, they take us behind-the-scenes with the PolarisDMD experience. Learn what it’s like to participate in their PolarisDMD clinical trial. Read the full newsletter here.
For Many Boys With Duchenne Muscular Dystrophy, Bright Hope Lies Just Beyond Reach
Scientists are testing nearly two dozen treatments that might stop the disease. But enrollment in the trials is very restricted, and few children qualify. Lucas was 5 before his parents, […]
Striving for a Cure – Newport Beach Magazine
When their only son, Hawken, who is now 22, was diagnosed in 2002 with the progressive, muscle-wasting disease Duchenne muscular dystrophy, Paul and Debra Miller took swift action. Read the […]
CureDuchenne Sets Calendar for Workshops, Sessions and ‘Futures’ Conference
CureDuchenne, one of the nation’s leading Duchenne muscular dystrophy (DMD) charities, is sponsoring 30 events across the U.S. this year to educate patients and their families about all aspects of […]
Inaugural “Love Cures” Event Raises Funds to Help Find a Cure for Duchenne Muscular Dystrophy
Funds raised will be donated to the national nonprofit, CureDuchenne NEWPORT BEACH, Calif., Feb. 28, 2019 – The inaugural “Love Cures” event recently held in San Diego at the Del […]
CureDuchenne Cares Announces Annual FUTURES Conference and Line-up of 30 Educational Events for Duchenne Community in 2019
NEWPORT BEACH, Calif., Feb 26, 2019 – CureDuchenne, the nonprofit global leader in Duchenne research, patient care and innovation, announced today that its CureDuchenne Cares program will offer the Duchenne […]
The Phase 3 PolarisDMD Trial Goes Global
With a flurry of recent activity, 17 trial sites are now open for enrollment. We are especially excited to share that our first international sites in Canada and Australia have […]